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Summary Streptococcus mutans, a pathogen of dental caries, is known to be associated with
bacteremia and infective endocarditis (IE). The bacterium has been classified into four serotypes,
c, e, f, and k, based on the chemical composition of the serotype-specific rhamnose-glucose
polymers. Serotype k, recently designated and initially found in blood isolates, features a drastic
reduction of glucose side chains attached to the rhamnose backbone. Glucosyltransferases
(GTFs), protein antigen (PA), and glucan-binding proteins (Gbps) are major surface protein
antigens of S. mutans, and in vitro analyses using isogenic mutants without those cell surface
proteins showed that a PA-defective mutant had the least susceptibility to phagocytosis. Further,
rat experiments demonstrated that infection with such defective mutants resulted in a longer
duration of bacteremia, while S. mutans strains without GTFs were isolated from the extirpated
heart valve of an IE patient. These results imply that some variation of cell surface components is
correlated to the virulence of IE caused by S. mutans. In addition, S. mutans DNA has been
frequently identified in cardiovascular specimens at a higher ratio than other periodontal
bacteria, indicating its possible involvement in various types of cardiovascular diseases beside
bacteremia and IE.
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Table 1 Major surface protein antigens of S. mutans and their coding genes
Protein
antigen
Gene name GenBank
locus tag
Definition Gene
length
Estimated molecular
weight (Da)
GTFB gtfB SMU.1004 Glucosyltransferase-I 4431 165,733
GTFC gtfC SMU.1005 Glucosyltransferase-SI 4368 162,970
GTFD gtfD SMU.910 Glucosyltransferase-S 4389 163,393
PA pac SMU.610 Cell surface antigen 4689 169,997
GbpA gbpA SMU.2112c Glucan-binding protein 1698 63,118
GbpB gbpB SMU.22 Glucan-binding protein B 1296 44,608
GbpC gbpC SMU.1396c Glucan-binding protein C 1752 63,340
GbpD gbpD SMU.772 Bifunctional glucan-binding
protein D and lipase
2181 79,780
The description of each protein antigen and its coding gene in the strain UA159 was extracted from the ORALGEN database (http://
www.oralgen.lanl.gov/).
Figure 1 Illustration of chemical composition of serotype-
specific polysaccharides in S. mutans.
30 K. Nakano et al.1. Streptococcus mutans and dental caries
Streptococcusmutans, a Gram-positive facultative anaerobic
bacterium, is generally known to be a pathogen of dental
caries [1], and its surface protein antigens have been inves-
tigated to clarify their role as virulence factors. Glucosyl-
transferases (GTFs), protein antigen (PA), and glucan-binding
proteins (Gbps) are known to be major surface protein anti-
gens of S. mutans (Table 1), with three types of GTFs (GTFB/
GTFC/GTFD) shown to be involved in sucrose-dependent
adhesion to tooth surfaces [2—4]. GTFB and GTFD are
reported to produce insoluble and soluble glucans, respec-
tively, from sucrose, while GTFC is involved with the produc-
tion of both types of glucan. In contrast, PA [5] also referred
to SpaP [6], antigen I/II [7], antigen B [8], SR [9], IF [10], P1
[11], and MSL-1 [12], has been shown to be correlated with
sucrose-independent initial adhesion to tooth surfaces. Four
types of Gbps (GbpA/GbpB/GbpC/GbpD) of S. mutans are
also regarded as virulence factors for dental caries, due to
their glucan-binding properties [13—16]. In vitro analyses to
elucidate the mechanism of dental caries have been carried
out using isogenic mutants defective of target proteins,
which were constructed by inactivation of the genes encod-
ing each protein antigen [17—19]. Animal experiments using
specific pathogen-free rats orally infected with isogenic
mutants and their parent strain showed a significant involve-
ment of these protein antigens with dental caries [20—22].
2. Serotypes of S. mutans
Until recently, S. mutans was classified into three serotypes,
c, e, and f, based on the chemical composition of serotype-
specific rhamnose-glucose polymers (RGPs), which are com-
posed of a backbone of rhamnose and side chains of a1,2-
(serotype c), b1,2-(serotype e) and a1,3-(serotype f) gluco-
sidic residues (Fig. 1) [23]. Genes involved in the biosynthesis
of RGPs have been cloned and sequenced, of which four rml
genes (rmlA-D) are known to be related to the synthesis of
dTDP-L-rhamnose, a rhamnose backbone unit [24,25]. On the
other hand, gluA is known to be involved in the production of
the immediate precursor of the glucose side chain [26], and
the six-gene operon (rgpA-rgpF) and rgpG, which are
required for the synthesis of RGPs, have also been cloned
and sequenced [27,28]. In addition, genes located just down-stream of the rgpA-rgpF operon have been sequenced. This
region was shown to be highly diverse among the serotypes
and a PCR method for specification of each serotype was
constructed using the nucleotide alignments specific for each
serotype in the region [29].
Several non-c/e/f S. mutans strains have been described
in previous reports. However, only a single study has provided
information regarding the sugar composition of RGPs. Fig. 2
shows the sugar composition of purified serotype-specific
polysaccharides analyzed by high-liquid performance chro-
matography, which identified a drastic reduction in the
amount of glucose in a non-c/e/f strain (TW295) isolated
from human blood as compared to the reference strain
(MT8148) [30]. S. mutans serotype-specific antisera are gen-
erally produced by intramuscular immunization of whole
cells in rabbits, however, antisera for non-c/e/f strains
cannot be produced by the conventional method. A modifica-
tion of the immunization protocol by repeated intravenous
injections of whole cells resulted in successful generation of
antisera specific against these strains, which led to the
recent designation of novel serotype k [31]. Thereafter,
non-c/e/f strains from saliva and dental plaque samples
taken from Japanese children were classified as serotype k
when analyzed by an immunodiffusion technique using ser-
otype k-specific antiserum [32].
The prevalence rates of serotypes of S. mutans presented
in past articles are summarized in Table 2 [29,31—43]. There
Table 2 Prevalence of S. mutans serotypes reported in previous reports
Authors a Country Publication
year
Methods Total
subjects
Total
strains
Serotype prevalence (%)
c e f Non-c/e/f
Bratthall [33] England
and othersb
1970 Immunodiffusion — 56 89.3 8.9 1.8 (non-c/e) c
Perch et al. [34] Denmark 1974 Fluorescent
antibody
— 171 83.0 7.0 5.3 4.7d
Huis in’t Veld
et al. [35]
Netherlands 1979 Ring precipitation — 100 77.0 13.0 10.0 0
Hamada
et al. [36]
Japan 1980 Immunodiffusion — 997 68.9 13.3 17.8 0
Fitzgerald
et al. [37]
USA 1983 Fluorescent
antibody
— 96 67.7 11.5 4.2 16.7
Holbrook and
Beighton [38]
Iceland 1986 Immunodiffusion 63 78 73.1 24.4 2.6 (non-c/e) c
Beighton et al. [39] UK 1987 Immunodiffusion 59 69 72.5 26.1 1.4 (non-c/e) c
Batoni et al. [40] Italy 1993 ELISA — 136 78.7 (c and f) 16.2 — 5.1
Kozai et al. [41] Japan 1999 Immunodiffusion 68 114 84.2 15.8 0 0
Hirasawa and
Takada [42]
Japan 2003 Immunodiffusion 85 93 64.5 24.7 1.1 9.7
Shibata et al. [29] Japan 2003 PCR 211 — 84.4 13.9 1.9 0.5
Nakano et al. [31]e Japan 2004 Immunodiffusion — 1326 85.3 12.3 2.4 0
Nakano et al. [31] f Japan 2004 Immunodiffusion 100 100 78.0 17.0 3.0 2.0 (k)
Nakano et al. [31] g Japan 2004 Immunodiffusion 50 2500 70.8 22.0 5.2 2.0 (k)
Nakano et al. [43]h Japan 2004 PCR 137 — 72.8 21.9 4.1 1.2 (k)
aNumbers in parentheses indicate reference numbers. bSweden, Switzerland, and USA. cOMZ175, which was classified as f in a following study.
dMay include both non-c/e/f S. mutans and S. sobrinus strains. e,f,g,hYear of isolation; e1982—1990, f2002, g2003 and h2005—2006.
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which an immunodiffusion method using cell extract antigens
and serotype-specific antisera is commonly utilized. Further,
PCR methods that identify serotype using bacterial DNA have
been recently developed [29,32]. With those, isolation of
strains is not necessary for serotype determination, as the
serotypes of S. mutans in saliva, dental plaque, and other
tissues can be easily specified. In addition, detection sensi-
tivity has been shown to be higher with such a PCR method as
compared to a conventional immunodiffusion technique [32].
The detection rate of serotype c strains has been reported
to be the highest (ranging from 64.5 to 89.3%), followed by
serotype e (from 7.0 to 26.1%) (Table 2) [29,31—43]. In
contrast, the detection rate of serotype f is estimated to
be less than 5%, based on the results of previous studies,
though a higher frequency was reported in early studies. Prior
to the designation of serotype k, there were several reports
of the existence of non-c/e/f serotype in samples from
subjects in European countries, as well as from the United
States and Japan. It is not possible to speculate whether
those strains belong to serotype k, since no description of the
sugar composition of their serotype-specific RGPs was pro-
vided. The distribution of serotype k organisms in the oral
cavity has been estimated to range from 2 to 5%, based on
studies held in Japan [31,32]. Recently, Waterhouse and
Russell [44] designated a strain originally isolated in the
UK in the 1990s (strain 21) as serotype k. In addition, several
non-c/e/f S. mutans strains isolated in Finland in the early
1990s were recently classified as serotype k [45]. These
findings indicate that serotype k strains exist outside of
Japan, including some previously reported non-c/e/f strains.It would be interesting to understand the evolution of
each serotype of S. mutans. A recently completed multilocus
sequence typing scheme for S. mutans showed that serotype
c strains were widely distributed in the dendrograms, and
that serotypes e, f, and k strains were differentiated into
clonal complexes [45]. Therefore, the ancestral strain of S.
mutans may be serotype c, with the other serotypes con-
tinuously branched from serotype c groups.
3. Serotype k strains
An analysis of genes involved in the biosynthesis of serotype-
specific RGPs found that the serotype k-specific nucleotide
alignment was present in the 50 region of the rgpF gene
(350 bp from the initial sequence), thus the PCRmethod used
for identification of serotype k was constructed using the
alignment of that region [32]. It is speculated that an altera-
tion of the rgpF alignment in serotype k strains as compared
to other serotypes may cause the drastic reduction of glucose
side chains evident in those RGPs. However, the serotype of
mutants constructed from serotype c strains, in which the
rgpF sequence was replaced with that of serotype k strains,
was shown to be serotype c, indicating that an alteration of
rgpF is not associated with a reduction of glucose side chains
in RGPs [46]. On the other hand, mRNA expression of rgpEwas
found to be diminished in serotype k strains in a following
study, which was estimated to be the major cause of the
glucose side chain reduction commonly identified in serotype
k strains [46].
Isolation and designation of serotype k S. mutans strains
have been reported in several studies, with the cariogenicity
Figure 3 Phagocytosis susceptibility of S. mutans MT8148 and
isogenic mutants defective of major surface proteins. Fisher’s
PLSD analysis (*P < 0.05 and ***P < 0.001 against MT8148).
Figure 2 Sugar composition analysis of purified serotype-spe-
cific polysaccharides of S. mutans by high-performance liquid
chromatography.
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those [47]. That strain exhibited lower caries-inducing prop-
erties in vitro as well as in a rat model of dental caries due to
attenuation of its GbpC expression. In addition, GbpA expres-
sion was not detected in that strain due to a defect of the
gbpA gene [47]. When PA expression was analyzed in various
clinical isolates of S. mutans, defects of PA expression were
frequently identified in serotype k strains [18]. These results
indicate that alteration of cell surface proteins is another
characteristic of serotype k strains.
Since serotype k organisms feature a drastic reduction of
glucose side chains in the serotype-specific RGPs, it is impor-
tant to analyze the association of that glucose side chain
defect with virulence. Previous in vitro and in vivo assays
using glucose side chain-defective isogenic mutants indi-
cated that the glucose side chain itself is associated with
cariogenicity, though to a lesser extent than the other major
surface proteins of S. mutans [48]. In addition, glucose side
chain-defective mutants were shown to be significantly less
susceptible to phagocytosis by polymorphonuclear leuko-
cytes, indicating that serotype k strains may cause a longer
duration of bacteremia as compared to other serotypes [31].
4. S. mutans and bacteremia
Dissemination of oral bacteria into the bloodstream is known
to be induced by professional dental treatment and dailyoral care practices, such as tooth brushing and flossing, and
even food chewing [49]. Also, serotype-specific RGPs were
shown to contribute to the resistance to phagocytosis by
human polymorphonuclear leukocytes [50]. Previously, the
phagocytosis susceptibility of two S. mutans strains isolated
from patients with bacteremia (strains TW295 and MH1) was
evaluated following incubation of the tested bacteria
(5.0  107 CFU) with human peripheral blood (500 mL) at
37 8C for 10 min. The results showed that both had lower
phagocytosis rates as compared to the reference strain
MT8148 [31,51].
The phagocytosis susceptibility of GTF-, PA-, Gbp-defec-
tive isogenic mutant strains was also analyzed using the
same method, which showed that the PA-defective
mutant was the least susceptible to phagocytosis, followed
by a GbpC-defective strain (Fig. 3) [18,19]. In a rat
bacteremia model, infection with a PA-defective mutant
induced a significantly longer duration of bacteremia and
the inflammation marker reached significantly higher
levels than in rats infected with the parent strain [18].
Since this phenomenon was also observed with a GbpC-
defective mutant [52] and GbpC is known to have a high
homology with PA [15], PA and the related antigen are
possibly associated with the virulence of bacteremia
caused by S. mutans.
PA was also shown to be involved with the initial attach-
ment of cells to tooth surfaces, and its deficiency was
found to reduce cariogenicity in both in vitro and animal
model experiments [21,53]. On the other hand, PA was
reported to be immunodominant toward S. mutans anti-
gens when serum antibody responses to systemic infection
of oral streptococci were analyzed in humans [54]. Thus,
strains with a deficiency of PA expression are not only less
cariogenic, but also have fewer antigenic properties.
Therefore, it is reasonable to speculate that strains with-
out PA expression can survive in the bloodstream for a long
duration, causing the persistence of bacteremia.
Biofilm regulatory protein A (BrpA) is known to regulate
biofilm formation, while inactivation of the brpA gene encod-
ing BrpA was shown to cause its long chain formation [55,56].
Further, a BrpA-defective mutant was less susceptible to
S. mutans and cardiovascular diseases 33phagocytosis by polymorphonuclear leukocytes and increased
platelet aggregation properties as compared to its parent
strain [57]. It is possible that other unknown proteins related
to the virulence of bacteremia caused by S. mutans may be
found in future studies.
5. S. mutans and infective endocarditis
The incidence of infective endocarditis (IE) was calculated in
a review of 26 studies describing 3784 episodes of IE that
occurred between 1993 and 2003, and found to be 3.6 per
100,000 per year (range 0.3—22.4) [58]. According to a
review of 848 IE cases in Japan performed recently, the most
common type of microorganisms isolated from patients was
streptococcus species (49.5%), followed by staphylococcus
species (31.7%) [59]. Further, the most frequently detected
streptococcus species in patients with streptococcal valvular
diseases is known to be Streptococcus sanguinis, while S.
mutans was reported to be recovered from approximately
15% [60].
Table 3 summarizes a number of case reports of IE caused
by S. mutans. IE is known to be divided into acute and
subacute forms, and the bacterium is generally isolated in
subacute cases, in which fever, chills, sweats, anorexia,
weight loss, and malaise are common symptoms [61]. S.
mutans is detected in blood culture examinations in most
cases [62—70], though one patient with a negative blood
culture result on admission had S. mutans detected at the
second examination conducted 12 h later [66]. In two other
case reports, S. mutans was specified with a molecular
method using broad-range PCR and sequencing techniques
[69,70]. Oral conditions suspected to induce IE have also
been discussed in several reports [62—70]. However, the
associations of those conditions with the onset of IE remain
to be elucidated with a scientific approach in further studies
[71].
As for the pathogenesis of IE, its primary occurrence
results from bacterial adherence to damaged valves that
produces vegetation [58]. Thus, animal models of IE
require artificial damage to the heart valve by a catheter
in the location of vegetation formation. Several reports
have analyzed the contribution of the major cell surface
structures of S. mutans to the onset of IE using animal
models. Sucrose-derived exopolysaccharide was shown to
contribute to infectivity in endocarditis caused by an S.
mutans isogenic mutant strain with defects of all three
types of GTFs that was generated from the blood isolate
strain V403 [72]. However, S. mutans strains with a lack of
expression of all three types of GTFs have also been
isolated from infected heart valve tissues [70], indicating
that GTFs do not directly contribute to the virulence of IE
and that such defects may enhance the virulence of S.
mutans in IE. This speculation is supported by the results of
an animal experiment that demonstrated that the survival
rate of mice infected with an isogenic mutant strain lack-
ing all three types of GTFs was significantly lower than that
of those infected with the parent strain as well as the
uninfected control group [73].
Another animal experiment found that PA was not impor-
tant for the onset of IE, since a PA-defective mutant showed
similar adhesion properties to vegetation as the parent strain
[74]. In contrast, RGPs were shown to contribute to thevirulence of IE based on their properties of adhesion to
collagen type I and laminin [75]. The lipoprotein receptor
antigen I (LraI) was also shown to be important for the
development of IE [76]. In addition, the Cnm protein,
reported to function as a collagen-binding adhesin, was found
to have an association with the initial bacterial attachment
to blood vessels [77], and the rates of cnm-positive strains
among serotype f and k strains were shown to be significantly
higher than those of other serotypes [45]. Further, fibronec-
tin-binding protein, considered to be involved in bacterial
binding to extracellular matrix components such as fibrin,
platelets and fibronectin, was proposed to be one of the
crucial factors for IE caused by S. mutans [78]. As for platelet
aggregation, serotype-specific RGPs were shown to possess
properties that trigger platelet aggregation by direct binding
and activation [79].
A blood culture examination using samples from possible
IE patients is regarded as an important diagnostic tool,
while molecular methods have also been recommended for
diagnosis of IE [80]. Broad-range PCR and sequencing
techniques, in which amplification and nucleotide deter-
mination of 16S rRNA gene fragments using primers target-
ing the sequence common in eubacterial species, are
widely used to identify bacterial species [81]. Recently,
molecular analyses of extirpated heart valve specimens
from eight subacute IE cases were performed, and the
results showed that seven specimens contained S. mutans
DNA, of which five were positive for serotype k [82].
However, since the number of specimens was quite low,
whether serotype k S. mutans was incidentally detected
due to dissemination from the oral cavity or is an actual
pathogen in each of the cases of IE remains to be eluci-
dated. Nevertheless, it is possible to speculate that ser-
otype k S. mutans possesses properties that allow it to
survive in the bloodstream.
6. Detection of S. mutans in heart valve and
atheromatous plaque specimens
Dental caries and periodontitis are generally considered to
be major diseases in the field of dentistry. Recent evidence
has indicated an association of periodontitis with cardio-
vascular diseases [83,84], and several studies have focused
on the detection of periodontitis-related bacterial species
in cardiovascular specimens [85—87]. However, the oxida-
tive condition in the bloodstream must also be considered,
as it gives oral streptococci survival advantages as com-
pared to obligate anaerobic periodontitis-related bacterial
species. In a recent study, S. mutans DNA was most fre-
quently detected (approximately 70%) in cardiovascular
specimens from heart valves and atheromatous plaque from
Japanese patients, when the presence of six oral strepto-
cocci and six periodontitis-related bacterial species was
simultaneously examined (Fig. 4) [88]. A study held in the
United States also reported the presence of S. mutans in
cardiovascular specimens, though the frequency was rela-
tively low at approximately 20% [89]. As for the serotype
distribution of S. mutans detected in patients who have
undergone cardiovascular surgery, non-c serotypes were
identified with a significantly higher frequency in both
cardiovascular and dental plaque specimens as compared
Table 3 Summary of case reports of infective endocarditis caused by S. mutons
Authorsa Country Year Age Gender Cardiac condition Blood cultureb Oral condition
or manipulation
suspected to
induce IE
Lockwood
et al. [62]
USA 1974 43 F Rheumatic disease S. mutans Tooth extraction
with no prohylaxis
McGhie
et al. [63]
UK 1976 55 M IE (45 Y)/mitral
regurgitation
S. mutans (9) Scaling and polishing
42 F Heart murmur S. mutans Not described
38 M Mitral regurgitation S. mutans (4) Not described
Smith
et al. [64]
USA 1977 41 F Questionable history
of heart murmur
S. mutans (10/11) Minor dental work
Moore
et al. [65]
Ireland 1977 28 M Ventricular septal
defect (repaired)
S. mutans (6/6) Dental caries/
abscessed teeth
Robbins
et al. [66]
USA 1977 60 F Heart murmur S. mutans (5/6) Dental caries/
abscessed teeth
53 M Heart murmur due
to aortic insufficiency
Negative on
admission/
S. mutans 12 h
after that
Not described
61 M Heart murmur S. mutans (3/13) Not described
Vose
et al. [67]
USA 1987 42 F Not described S. mutans (4/4) Filling of dental
caries without
prophylaxis
!S. mutans (6/6) Dental cleaning
with prophylaxis
!S. mutans (6/6) Root canal
treatment with
prophylaxis
Ullman
et al. [68]
USA 1988 69 F Rheumatic heart
disease
S. mutans (5/5) Not described
53 M Questionable history
of heart murmur
S. mutans (4/4) Fractured
reconstructed
tooth/abscess
56 F Idiopathic
hypertrophic
subaortic stenosis
S. mutans (6/6) Not described
Gauduchon
et al. [69]
France 2001 63 M Aortic stenosis S. mutans (3/3) Abscessed teeth
Nomura
et al. [70]
Japan 2006 61 M Valve replacement
(59Y)
Not available Severe dental caries
a Numbers in parentheses indicate reference numbers.
b Values in parentheses indicate the number of positive cultures. If available, the total number of blood culture examination are included.
Arrows indicate recurrent IE.
34 K. Nakano et al.to serotype c, which was detected in 70—75% of the samples
from healthy subjects [43].
Few reports have provided a clear explanation for the
association of periodontitis-related bacterial species with
cardiovascular diseases in animal models, though one study
showed that systemic challenge by P. gingivalis resulted in an
acceleration of atherogenic plaque formation in a mouse
model [90]. P. gingivalis was also shown to induce platelet
aggregation and foam cell formation, both of which are
known to be important steps in the development of ather-omatous plaque [91,92]. It is also of interest that S. mutans
was shown to possess these two properties [57,79,92], indi-
cating that the bacterium is a possible candidate for inclusion
in the group of bacterial species involved with atheromatous
plaque formation. In addition, S. mutans cells bind to extra-
cellular matrix molecules and fibrinogen [93], which is also
regarded as advantageous for plaque formation. However,
additional investigations with animal models are required to
clarify the association between S. mutans and atheromatous
plaque formation.
Figure 4 Detection rates of oral bacterial species in heart valve and atheromatous plaque specimens.
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